No profile data available.
Quantum BioPharma Ltd. (QNTM) is a healthcare company in the brain and nerve treatment drugs industry, based in Toronto, Canada.
It reported revenue of $0 for fiscal year 2025, and net income of -$26.18 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $18.90 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Quantum BioPharma reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$18.90 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include TAO Synergies Inc. (TAOX), Aytu BioPharma, Inc. (AYTU), Psyence Biomedical Ltd. (PBM), ProMIS Neurosciences, Inc. (PMN).